|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net earnings | |||||
| Noncash items: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Share-based compensation | |||||
| Loss on sale of subsidiary and subsidiaries held for sale | |||||
| Net gains on dispositions and other strategic transactions | |||||
| Other, net | |||||
| Net change in other operating items, net of effects from acquisitions and dispositions: | |||||
| Accounts receivable | |||||
| Other assets | |||||
| Medical costs payable | |||||
| Accounts payable and other liabilities | |||||
| Unearned revenues | |||||
| Cash flows from operating activities | |||||
| Investing activities | |||||
| Purchases of investments | |||||
| Sales of investments | |||||
| Maturities of investments | |||||
| Cash paid for acquisitions and other transactions, net of cash assumed | |||||
| Purchases of property, equipment and capitalized software | |||||
| Loans to care providers - cyberattack | |||||
| Repayments of care provider loans - cyberattack | |||||
| Cash received from dispositions, net | |||||
| Originations and purchases of loans | |||||
| Repayments and maturities of loans | |||||
| Other, net | |||||
| Cash flows used for investing activities | |||||
| Financing activities | |||||
| Common share repurchases | |||||
| Proceeds from common stock issuances | |||||
| Repayments of long-term debt | |||||
| Proceeds from (repayments of) short-term borrowings, net | |||||
| Proceeds from issuance of long-term debt | |||||
| Customer funds administered | |||||
| Purchases of redeemable noncontrolling interests | |||||
| Other, net | |||||
| Cash flows used for financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| (Decrease) increase in cash and cash equivalents, including cash within businesses held for sale | |||||
| Less: net increase in cash within businesses held for sale | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental cash flow disclosures | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes |
Loading...
